Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 808320, 7 pages
http://dx.doi.org/10.1155/2014/808320
Clinical Study

Anticoagulation Strategies in Venovenous Hemodialysis in Critically Ill Patients: A Five-Year Evaluation in a Surgical Intensive Care Unit

1Department of Anaesthesiology and Critical Care Medicine, Jena University Hospital, Erlanger Allee 101, 07747 Jena, Germany
2Center for Sepsis Control and Care (CSCC), Integrated Research and Treatment Center, Jena University Hospital, 07747 Jena, Germany

Received 14 July 2014; Revised 10 November 2014; Accepted 15 November 2014; Published 9 December 2014

Academic Editor: Monica Rocco

Copyright © 2014 Christoph Sponholz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Uchino, J. A. Kellum, R. Bellomo et al., “Acute renal failure in critically ill patients: a multinational, multicenter study,” Journal of the American Medical Association, vol. 294, no. 7, pp. 813–818, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. de Mendonça, J.-L. Vincent, P. M. Suter et al., “Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score,” Intensive Care Medicine, vol. 26, no. 7, pp. 915–921, 2000. View at Google Scholar · View at Scopus
  3. Z. Ricci and C. Ronco, “Timing, dose and mode of dialysis in acute kidney injury,” Current Opinion in Critical Care, vol. 17, no. 6, pp. 556–561, 2011. View at Publisher · View at Google Scholar
  4. A. Davenport, “What are the anticoagulation options for intermittent hemodialysis?” Nature Reviews Nephrology, vol. 7, no. 9, pp. 499–508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. H. M. O. Straaten, J. A. Kellum, and R. Bellomo, “Clinical review: anticoagulation for continuous renal replacement therapy—heparin or citrate?” Critical Care, vol. 15, article 202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Sakr, F. Haetscher, M. D. Gonsalves et al., “Heparin-induced thrombocytopenia type II in a surgical intensive care unit,” Journal of Critical Care, vol. 27, no. 3, pp. 232–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-Y. Wu, Y.-H. Hsu, C.-H. Bai, Y.-F. Lin, C.-H. Wu, and K.-W. Tam, “Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials,” American Journal of Kidney Diseases, vol. 59, no. 6, pp. 810–818, 2012. View at Publisher · View at Google Scholar
  8. Z. Zhang and N. Hongying, “Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy,” Intensive Care Medicine, vol. 38, no. 1, pp. 20–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Uchino, R. Bellomo, H. Morimatsu et al., “Continuous renal replacement therapy: a worldwide practice survey: the beginning and ending supportive therapy for the kidney (B.E.S.T. Kidney) investigators,” Intensive Care Medicine, vol. 33, no. 9, pp. 1563–1570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Kalb, R. Kram, S. Morgera, T. Slowinski, and D. Kindgen-Milles, “Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk,” Therapeutic Apheresis and Dialysis, vol. 17, no. 2, pp. 202–212, 2013. View at Publisher · View at Google Scholar
  11. S. Morabito, V. Pistolesi, L. Tritapepe et al., “Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution,” Critical Care, vol. 16, no. 3, article R111, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. H. Saner, J. W. Treckmann, A. Geis et al., “Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy,” Nephrology, Dialysis, Transplantation, vol. 27, no. 4, pp. 1651–1657. View at Publisher · View at Google Scholar
  13. M. Schetz, “Vascular access for HD and CRRT,” Contributions to Nephrology, vol. 156, pp. 275–286, 2007. View at Publisher · View at Google Scholar
  14. A. Vijayan, “The clinical application of CRRT—current status: vascular access for continuous renal replacement therapy,” Seminars in Dialysis, vol. 22, no. 2, pp. 133–136, 2009. View at Publisher · View at Google Scholar
  15. J.-J. Parienti, B. Mégarbane, M.-O. Fischer et al., “Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study,” Critical Care Medicine, vol. 38, no. 4, pp. 1118–1125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. E. Dugué, S. P. Levesque, M.-O. Fischer et al., “Vascular access sites for acute renal replacement in intensive care units,” Clinical Journal of the American Society of Nephrology, vol. 7, no. 1, pp. 70–77, 2012. View at Publisher · View at Google Scholar
  17. J. van de Watering, R. G. J. Westendorp, J. G. van der Hoeven, B. Stolk, J. D. M. Feuth, and P. C. Chang, “Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage,” Journal of the American Society of Nephrology, vol. 7, no. 1, pp. 145–150, 1996. View at Google Scholar · View at Scopus
  18. H. M. Oudemans-van Straaten, J. P. J. Wester, A. C. J. M. de Pont, and M. R. C. Schetz, “Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?” Intensive Care Medicine, vol. 32, no. 2, pp. 188–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. G. R. Hetzel, M. Schmitz, H. Wissing et al., “Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial,” Nephrology, Dialysis, Transplantation, vol. 26, no. 1, pp. 232–239, 2011. View at Publisher · View at Google Scholar
  20. M. Monchi, D. Berghmans, D. Ledoux, J.-L. Canivet, B. Dubois, and P. Damas, “Citrate versus heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study,” Intensive Care Medicine, vol. 30, no. 2, pp. 260–265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. J. Kutsogiannis, R. T. N. Gibney, D. Stollery, and J. Gao, “Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients,” Kidney International, vol. 67, no. 6, pp. 2361–2367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. M. O. Straaten, R. J. Bosman, M. Koopmans et al., “Citrate anticoagulation for continuous venovenous hemofiltration,” Critical Care Medicine, vol. 37, no. 2, pp. 545–552, 2009. View at Publisher · View at Google Scholar
  23. M. G. H. Betjes, D. van Oosterom, M. van Agteren, and J. van de Wetering, “Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: Similar hemofilter survival but significantly less bleeding,” Journal of Nephrology, vol. 20, no. 5, pp. 602–608, 2007. View at Google Scholar · View at Scopus
  24. R. Claure-Del Granado, E. Macedo, S. Soroko et al., “Anticoagulation, delivered dose and outcomes in CRRT: the program to improve care in acute renal disease (PICARD),” Hemodialysis International, vol. 18, no. 3, pp. 641–649, 2014. View at Publisher · View at Google Scholar
  25. M. E. Jaax and A. Greinacher, “Management of heparin-induced thrombocytopenia,” Expert Opinion on Pharmacotherapy, vol. 13, no. 7, pp. 987–1006, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Selleng, S. Selleng, and A. Greinacher, “Heparin-induced thrombocytopenia in intensive care patients,” Seminars in Thrombosis and Hemostasis, vol. 34, no. 5, pp. 425–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Joannidis and H. M. O. Straaten, “Clinical review: patency of the circuit in continuous renal replacement therapy,” Critical Care, vol. 11, article 218, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Baldwin, “Factors affecting circuit patency and filter 'life',” Contributions to Nephrology, vol. 156, pp. 178–184, 2007. View at Google Scholar
  29. S. Morgera, C. Scholle, G. Voss et al., “Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience,” Nephron—Clinical Practice, vol. 97, no. 4, pp. c131–c136, 2004. View at Publisher · View at Google Scholar · View at Scopus